All posts in category Basal Cell Carcinoma

Non-Melanoma Skin Cancer & SNPs

A Community-Based Study of Nucleotide Excision Repair Polymorphisms in Relation to the Risk of Non-Melanoma Skin Cancer Anthony J. Alberg, PhD, MPH Blatt Ness Professor Division of Biostatistics and Epidemiology, Department of Medicine Associate Director for Cancer Prevention and Control Medical University of South Carolina Charleston, SC USA What are the main findings of the [...]

No Comments
by on April 18, 2012  •  Permalink
Posted in Author Interviews, Basal Cell Carcinoma, Skin Cancer
Tagged
Posted by admin on April 18, 2012

http://dermatologistsblog.com/skin-cancer/non-melanoma-skin-cancer-snps/

Basal Cell Carcinomas of the Face, Incomplete Excisions & Solar Elastosis

Assessment of Incompletely Excised Basal Cell Carcinomas in Six Facial Areas: Influence of Elastosis. Author Interview: Husein Husein-ElAhmed MD Department of Dermatology, University Hospital, Granada, Spain What are the main findings of the study? Answer: In our research we found that there are areas where BCC show higher rate of incomplete excision: These are were [...]

No Comments
by on April 18, 2012  •  Permalink
Posted in Author Interviews, Basal Cell Carcinoma, Skin Cancer
Tagged ,
Posted by admin on April 18, 2012

http://dermatologistsblog.com/skin-cancer/basal-cell-carcinomas-of-the-face-incomplete-excisions-solar-elastosis/

FDA Approves Vismodegib for Advanced or Metastatic Basal Cell Carcinoma

On January 30, 2012, the U. S. Food and Drug Administration approved vismodegib (ERIVEDGE Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation. Efficacy was [...]

No Comments
by on February 1, 2012  •  Permalink
Posted in Basal Cell Carcinoma, Skin Cancer
Tagged
Posted by admin on February 1, 2012

http://dermatologistsblog.com/skin-cancer/fda-approves-vismodegib-for-advanced-or-metastatic-basal-cell-carcinoma/

Indoor tanning and risk of early-onset basal cell carcinoma | Author Interview Dr. Mayne

Indoor tanning and risk of early-onset basal cell carcinoma Author Interview: Susan T. Mayne, PhD Yale School of Public Health, 60 College St, PO Box 208034, New Haven, CT What are the main findings of the study? The main finding of our case-control study is that indoor tanning was identified as an important risk factor [...]

1 Comment
by on December 25, 2011  •  Permalink
Posted in Author Interviews, Basal Cell Carcinoma, Skin Cancer, Tanning Booths
Tagged , , , ,
Posted by admin on December 25, 2011

http://dermatologistsblog.com/tanning-booths/indoor-tanning-and-risk-of-early-onset-basal-cell-carcinoma-author-interview-dr-mayne/